[1]吕超,石清兰,覃倩,等.藏、维两族常用保肝药物研究进展[J].西部中医药,2021,34(07):153-157.[doi:10.12174/j.issn.2096-9600.2021.07.39]
　LYU Chao,SHI Qinglan,QIN Qian,et al.Advances in Research on Common Liver Protective Drugs Used in Tibetan and Uygur[J].Western Journal of Traditional Chinese Medicine,2021,34(07):153-157.[doi:10.12174/j.issn.2096-9600.2021.07.39]
点击复制

藏、维两族常用保肝药物研究进展
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
34
期数:
2021年07期
页码:
153-157
栏目:
研究进展
出版日期:
2021-07-15

文章信息/Info

Title:
Advances in Research on Common Liver Protective Drugs Used in Tibetan and Uygur
作者:
吕超1, 石清兰2, 覃倩1, 毛德文2
1.广西中医药大学,广西 南宁 530222
2.广西中医药大学第一附属医院
Author(s):
LYU Chao1, SHI Qinglan2, QIN Qian1, MAO Dewen2
1.Guangxi University of Chinese Medicine, Nanning 530222, China
2.The First Affiliated Hospital of Guangxi University of Chinese Medicine
关键词:
肝损伤; 保肝作用; 化学成分; 藏族; 维吾尔族
Keywords:
liver injury; liver protection; chemical ingredients; Tibetan; Uygur
分类号:
R291
DOI:
10.12174/j.issn.2096-9600.2021.07.39
摘要:
综述近年来藏、维两族常用护肝药物的作用机制，指出藏、维两族常用护肝药物提取物如多糖类、黄酮类、苷类、生物碱类、挥发油类有效物质可通过抗氧化、激活提高免疫力、抗细胞凋亡、促进肝细胞再生等作用对肝脏起保护作用。
Abstract:
By reviewing the mechanism of common liver protective drugs used in Tibetan and Uygur in the recent years, it is pointed out that the extracts of common liver protective drugs including polysaccharides, flavonoids, glycosides, alkaloids and volatile oils can protect the liver through antioxidation, activating and improving immunity, resisting cellular apoptosis, promoting hepatocyte regeneration.

相似文献/References:

[1]黄清杰,李茂星,刘 雄△.中医治疗药物性肝损伤研究进展[J].西部中医药,2012,25(07):124.
　HUANG Qing-jie,LI Mao-xing,LIU Xiong.Progress of Study on Treatment of Drug-induced Liver Injury with TCM[J].Western Journal of Traditional Chinese Medicine,2012,25(07):124.
[2]孟宪华,陈德道,张樱山,等.藏药“桑蒂”抗肝损伤作用机制研究[J].西部中医药,2014,27(01):135.
　MENG Xianhua,CHEN Dedao,ZHANG Yingshan,et al.Study on the Mechanism of Tibetan Medicine "SangDi" Fighting against Liver Damage[J].Western Journal of Traditional Chinese Medicine,2014,27(07):135.
[3]吕培,何红彦,曹红涛,等.冬虫夏草制剂对抗结核药物致肝肾损伤的“减毒”作用及其机制[J].西部中医药,2020,33(03):16.[doi:10.12174/j.issn.1004-6852.2020.03.05]
　LYU Pei,HE Hongyan,CAO Hongtao,et al.The "Attenuation" Actions and the Mechanism of Dongchong Xiacao Preparation on Liver and Kidney Injury of Antituberculosis Drugs[J].Western Journal of Traditional Chinese Medicine,2020,33(07):16.[doi:10.12174/j.issn.1004-6852.2020.03.05]
[4]李艳,刘丽丽,杨小军,等.慢性乙型肝炎肝郁脾虚证患者中医证候及实验室指标特征观察[J].西部中医药,2022,35(03):72.[doi:10.12174/j.issn.2096-9600.2022.03.17]
　LI Yan,LIU Lili,YANG Xiaojun,et al.Observation on the Characteristics of TCM Syndromes and Lab Indicators of Patients with Chronic Hepatitis B of Liver Depression and Spleen Deficiency Pattern[J].Western Journal of Traditional Chinese Medicine,2022,35(07):72.[doi:10.12174/j.issn.2096-9600.2022.03.17]

备注/Memo

备注/Memo:
吕超（1993—），男，硕士学位。研究方向：肝病的中医药防治。国家自然科学基金（81760849）；广西中医药大学2018年研究生教育创新计划项目（YCSZ2018009）。
更新日期/Last Update: 2021-07-15